BIND Therapeutics, Inc. (BIND) - NASDAQ

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Company Description
BIND Therapeutics, Inc. is a clinical stage nanomedicine platform company. The company develops Accurins, which are selective and programmable therapeutics. It main drug candidates are BIND-014, is in Phase 2 clinical trials for non-small cell lung cancer and metastatic castrate-resistant... More
Sector: Healthcare
Industry: Biotechnology
Country: United States